Refractory Ascites: Clinical Trials

16 trials for Refractory Ascites, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 6 unknown, 3 not yet recruiting, 1 terminated. 5 Not applicable, 5 Phase 2, 4 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable5Completed 2, Not yet recruiting 2, Unknown 1
Phase 25Completed 2, Unknown 2, Not yet recruiting 1
Phase 34Completed 2, Unknown 2

Follow Refractory Ascites: new trials by email Literature Review of Refractory Ascites trials Research Report on Refractory Ascites

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Fiber-Optic Navigation During TIPS Creation: A Prospective Pilot Study
Fiber-Optic Navigation System - Liver Cirrhosis, Refractory Ascites
Not applicableNot yet recruitingMedical University Innsbruck302027-01-012026-03-13
Personalized Nutritional Intervention in Patients Undergoing TIPS Insertion for Refractory Ascites to Prevent Overt Hepatic Encephalopathy
High Energy and High Protein Diet 1, High Energy and High Protein Diet 2 - Cirrhosis, Refractory Ascites
Not applicableNot yet recruitingMcGill University Health Centre/Research Institute of the McGill University Health Centre502026-06-152026-06-08
Clinical Study to Evaluate the Efficacy and Safety of Dapagliflozin in Patients With Refractory Cirrhotic Ascites
Dapagliflozin 5mg, Standard care treatment - Refractory Ascites
Phase 2Not yet recruitingMansoura University702025-04-152025-04-09
Transjugular Intrahepatic Portosystemic Shunts Improve Survival in Patients With Cirrhosis and Recurrent Ascites
transjugular intrahepatic portal shunt - Refractory Ascites
CompletedTang-Du Hospital4622023-12-012024-08-27
Point-of-Care Echocardiography to Assess Impact of Dynamic Cardiac Function, Renal and Cardiac Biomarkers in Cirrhosis With Refractory Ascites
Echocardiographic assessment - Cirrhosis, Liver, Acute-On-Chronic Liver Failure
UnknownPost Graduate Institute of Medical Education and Research, Chandigarh802022-11-152023-09-21
Point-of-Care Echocardiography to Assess Impact of Dynamic Cardiac Function, Renal and Cardiac Biomarkers in Cirrhosis With Hepatorenal Syndrome-Acute Kidney Injury
Echocardiographic assessment - Hepatorenal Syndrome, Cirrhosis, Liver
UnknownPost Graduate Institute of Medical Education and Research, Chandigarh752021-12-152023-05-01
Midodrine and Albumin in Patients With Refractory Ascites
Albumin, Midodrine, Standard medical therapy (SMT) - Refractory Ascites
Phase 3UnknownPost Graduate Institute of Medical Education and Research, Chandigarh1142020-11-012020-11-09
Safety and Efficacy of Midodrine Hydrochloride in the Management of Refractory Ascites Due to Cirrhosis in Children
Midodrine 2.5 mg tab - Refractory Ascites, Children, Only
Not applicableUnknownNational Liver Institute, Egypt202020-06-052020-08-24
Evaluation of Hemodynamic Parameters Following Transjugular Intrahepatic Portosystemic Shunt (TIPS)
Study - Transjugular Intrahepatic Portosystemic Shunt (TIPS), Control - Transjugular Intrahepatic Portosystemic Shunt (TIPS) - Refractory Ascites
Not applicableCompletedMedical College of Wisconsin502019-09-252024-12-13
Glutamine Challenge as Predictor of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt (TIPS)
Oral glutamine challenge, Psychometric Tests - Refractory Ascites, Hepatic Hydrothorax
TerminatedUniversity of Arkansas32013-05-012017-04-17
ALFApump System Post Marketing Surveillance Registry
Liver Cirrhosis, Refractory Ascites
CompletedSequana Medical N.V.1002012-06-012020-10-26
Infrared Ray Heat Treatment in Liver Cirrhosis Patients With Refractory Ascites
Infrared ray heat treatment, conventional treatment - Liver Cirrhosis, Refractory Ascites
Phase 2 / Phase 3UnknownFirst People's Hospital of Foshan402012-03-012012-03-21
The Effectiveness of L-ornithine-L-aspartate (LOLA) on Plasma Ammonia in Cirrhotic Patients After TIPS
L-ornithine-L-aspartate - Decompensated Cirrhosis, Portal Hypertension
Phase 2 / Phase 3CompletedAir Force Military Medical University, China402011-12-012012-12-19
Effects of Treatment of Ascites by the ALFApump System on Renal and Circulatory Function
ALFApump system - Cirrhosis, Liver, Refractory Ascites
Phase 2UnknownSequana Medical N.V.122011-09-012016-08-11
A Feasibility Study of the Automated Fluid Shunt (AFS) for Automated Ascites Removal
AFS System - Refractory Ascites
Not applicableCompletedNovaShunt AG72008-12-012011-12-19
The Use of Drugs to Improve Kidney Function in Patients With Liver and Kidney Dysfunction
Midodrine, albumin, octreotide LAR, midodrine, octreotide, albumin - Type 2 Hepatorenal Syndrome, Refractory Ascites
Phase 2 / Phase 3CompletedUniversity of Alberta92005-10-012007-12-06

Narrower conditions

Ascites (16)  ·  Liver Cirrhosis (7)  ·  Fibrosis (3)  ·  Hypertension, Portal (3)  ·  Acute-On-Chronic Liver Failure (2)  ·  Hepatorenal Syndrome (2)  ·  Acute Kidney Injury (1)  ·  Hepatic Encephalopathy (1)  ·  Hydrothorax (1)

Broader conditions

Pathologic Processes (16)  ·  Pathological Conditions, Signs and Symptoms (16)  ·  Digestive System Diseases (9)  ·  Liver Diseases (9)  ·  Fibrosis (7)  ·  Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Hepatic Insufficiency (3)  ·  Kidney Diseases (3)  ·  Liver Failure (3)  ·  Male Urogenital Diseases (3)  ·  Urogenital Diseases (3)  ·  Urologic Diseases (3)  ·  Liver Failure, Acute (2)  ·  Brain Diseases (1)

Interventions

Midodrine (3)  ·  Albumins (2)  ·  Octreotide (1)  ·  Psychometrics (1)  ·  dapagliflozin (1)  ·  ornithylaspartate (1)

Sponsors

Post Graduate Institute of Medical Education and Research, Chandigarh (3)  ·  Sequana Medical N.V. (2)  ·  Air Force Military Medical University, China (1)  ·  First People's Hospital of Foshan (1)  ·  Mansoura University (1)  ·  McGill University Health Centre/Research Institute of the McGill University Health Centre (1)  ·  Medical College of Wisconsin (1)  ·  Medical University Innsbruck (1)  ·  National Liver Institute, Egypt (1)  ·  NovaShunt AG (1)  ·  Tang-Du Hospital (1)  ·  University of Alberta (1)  ·  University of Arkansas (1)

Countries

Canada (3)  ·  China (3)  ·  India (2)  ·  Spain (2)  ·  Switzerland (2)  ·  United States (2)  ·  Austria (1)  ·  Czechia (1)  ·  Egypt (1)  ·  Germany (1)  ·  United Kingdom (1)

Top investigators

Amine Benmassaoud, MD (1)  ·  Andrea De Gottardi, Privatdozent (1)  ·  Andres Duarte-Rojo, MD, MSc (1)  ·  Bassam Ayoub, MD (1)  ·  Eric J Hohenwalter, MD (1)  ·  Guohong Han, PhD & MD (1)  ·  Pere Gines, MD (1)  ·  Vincent Bain, MD, FRCPC (1)  ·  Virendra Singh, MD, DM (1)  ·  Yinong Ye, doctor (1)

Results publications

PMID 28940225, PMID 29973706, PMID 31342529, PMID 35686702, PMID 37976391